» Authors » Jessica de Ruijter

Jessica de Ruijter

Explore the profile of Jessica de Ruijter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 179
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wijburg F, Heap F, Rust S, de Ruijter J, Tump E, Marchal J, et al.
Mol Genet Metab . 2021 Oct; 134(4):317-322. PMID: 34600820
Introduction: Currently, there is no effective therapy for mucopolysaccharidosis IIIA (MPS IIIA). Intravenously-administered enzyme replacement therapies, while effective in other forms of MPS without neurological involvement, have not been successful...
2.
Jones S, Breen C, Heap F, Rust S, de Ruijter J, Tump E, et al.
Mol Genet Metab . 2016 May; 118(3):198-205. PMID: 27211612
Objective: This was an open-label, phase 1/2 dose-escalation, safety trial of intrathecal recombinant human heparan-N-sulfatase (rhHNS) administered via intrathecal drug delivery device (IDDD) for treating mucopolysaccharidosis IIIA (NCT01155778). Study Design:...
3.
de Ruijter J, Maas M, Janssen A, Wijburg F
Mol Genet Metab . 2013 Apr; 109(1):49-53. PMID: 23541797
Background: Sanfilippo disease, or Mucopolysaccharidosis type III (MPS III), is a lysosomal storage disorder and a member of the mucopolysaccharidoses (MPSs). MPS III is clinically characterized by progressive neurodegeneration. Skeletal...
4.
Albersen M, Bosma M, Knoers N, de Ruiter B, Diekman E, de Ruijter J, et al.
PLoS One . 2013 Jan; 8(1):e54113. PMID: 23342087
Background: Vitamin B6 is present in various forms (vitamers) in the diet that need to be metabolized to pyridoxal phosphate (PLP), the active cofactor form of vitamin B6. In literature,...
5.
de Ruijter J, de Ru M, Wagemans T, Ijlst L, Lund A, Orchard P, et al.
Mol Genet Metab . 2012 Oct; 107(4):705-10. PMID: 23084433
Introduction: Mucopolysaccharidoses (MPSs) are a group of lysosomal storage disorders (LSDs) caused by a defect in the degradation of glycosaminoglycans (GAGs). The accumulation of GAGs in MPS patients results in...
6.
de Ruijter J, Valstar M, Narajczyk M, Wegrzyn G, Kulik W, Ijlst L, et al.
Ann Neurol . 2012 Jan; 71(1):110-20. PMID: 22275257
Objective: Sanfilippo disease (mucopolysaccharidosis type III [MPS III]) is a rare neurodegenerative metabolic disease caused by a deficiency of 1 of the 4 enzymes involved in the degradation of heparan...
7.
de Vries A, de Ruijter J, de Mendonca Melo M, Wismans P, Vroon H, van Genderen P
Ned Tijdschr Geneeskd . 2010 Jan; 153:A950. PMID: 20051165
A 56-year-old man was admitted to hospital with complaints of headache, fever and photophobia, 3 weeks after being bitten by ticks in Southern Germany. Two weeks before admission he had...